U.S. Contraceptive Use METHOD WOMEN (ages (g 15-44) TUBAL LIGATION 28% Oral contraceptives 27% Male condom 21% VASECTOMY 11% Injectable 3% Diapragm 2%
Sterilization: Female Fe ale and Male Paula Bednarek, MD Assistant Professor Dept of Obstetrics and Gynecology Oregon Health & Science University
U....
Sterilization: Female Fe ale and Male Paula Bednarek, MD Assistant Professor Dept of Obstetrics and Gynecology Oregon Health & Science University
U.S. Contraceptive Use METHOD
WOMEN ((ages g 1515-44))
TUBAL LIGATION
28%
Oral contraceptives
27%
Male condom
21%
VASECTOMY
11%
Injectable
3%
Diapragm
2%
IUD
1% Piccino et al. Fam Plann Perspect. 1998
Contraceptive Efficacy Method
Pregnancies per 1000 women (5--year)) (5
IUD - Mirena® Mirena®
5
VASECTOMY
10
TUBAL LIGATION
13
IUD - ParaGard ParaGard® ®
14
Injectable
32
Oral contraceptives
70
Male condom
90
Periodic abstinence
198 Trussell et al. Fam Plann Perspect. 1999
Tubal Ligation
Timing
Post-partum PostPost--abortion Post Interval (unrelated to pregnancy)
Approaches
Mini-laparotomy MiniLaparoscopic Hysteroscopic Transvaginal (colpotomy) Ch i l sclerosing Chemical l i agentt - Quinacrine Q i i
Tubal Ligation
Anesthesia
General Regional g
Voluntary
Contraindications
Anesthesia Severe adhesions Severe dysmenorrhea
Mental disabilities Teenagers Medicaid
Informed consent
Explanation p of p procedure,, includingg anesthesia Benefits
Alternatives
Highly effective Reduction R d i iin risk i k off ovarian i cancer (OR 0.30.3 0 3-0.9) 0 9) andd PID Other forms of contraception p Vasectomy
Potential risks
Operative Failure Ectopic p p pregnancy g y No change in menstruation, sexual desire or pleasure
Post--sterilization regret Post
Overall 33-10% Associated with:
Not associated with:
Young age at time of sterilization Change in marital status R li i Religious b background k d Socioeconomic status Educational level Low parity Postpartum or post post--abortion sterilization
1-2% seek reversal
Mini--laparotomy Mini
Advantages g
Postpartum Local anesthesia Partial salpingectomy
Lower failure rate Tissue to pathology
Disadvantages
More postpost-op pain Longer recovery Wound healing
Opportunity to inspect abdomen B l visible Barely i ibl incision i ii scar(s) Rapid p recoveryy
Disadvantages
Operative risks Anesthesia risks Cost
Equipment Trainingg
Filschie® Filschie ® Clip
Falope® Falope ® Ring
Bipolar cautery
CREST Study
C ll b ti R Collaborative Review i off Sterilization St ili ti Study St d 10,685 women Prospectively P i l enrolled ll d cohort h Followed 88--14 years Outcomes (cumulative over 10 years)
18.5 pregnancies per 1000 procedures 7 3 ectopic 7.3 i pregnancies i per 1000 procedures d
Peterson, et al. Am J Obstet Gynecol. 1996
CREST: Failure by Method Method PP partial salpingectomy
Pregnancies per 1000 procedures 7.5
Unipolar coagulation
7.5
Falope ring
17.7
Interval partial salpingectomy
20.1
Bipolar coagulation
24.8 4.8
Hulka® Hulka ® clips
36.5
All methods
18 5 18.5 Peterson, et al. Am J Obstet Gynecol. 1996
Reasons for Failure
Surgeon failure Misidentification of structures Technical failure
Postpartum vs. Interval Method Loss to follow follow--up
Essure® Essure ® Procedure
Non--incisional, Non incisional transcervical permanent tubal occlusion Micro--inserts are placed in the fallopian tubes Micro Introduced with standard hysteroscopic approach h with i h tubal b l cannulation l i Can be performed in outpatient setting without general anesthesia
Essure® Essure ® Delivery System
Essure® Essure ® Procedure
3-month Hysterosalpingogram
Vasectomy
Worldwide
5% of married couples N Zealand New Z l d – 23% Netherlands – 11% China – 8% India – 7%
U.S.
11% (500,000 per year)
Vasectomy
Performed by Urologists (71.1%) Family y practitioners p (15.4%) ( %) General surgeons (12.9%)
Safer than tubal ligation Less invasive Local anesthesia